News for Medifast, Inc. (0K05.L)

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Revenue: $119 million for Q4 2024, a decrease of 37.7% year-over-year.Gross Profit: $88.2 million, down 37.6% year-over-year; Gross profit margin improved to 7

Feb 18, 2025 / 09:30PM GMTOperator Greetings, and welcome to the Medifast fourth-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, t

Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President, Investor...

Revenue: $119.0 million, surpassing the estimated $114.25 million for the quarter.Earnings Per Share (EPS): $0.07, exceeding the estimated EPS of -$0.16.Net In

[url="]Medifast[/url] (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, [url="]OPTA[/url][url="]VIA®

The following slide deck was published by Medifast, Inc.

Medifast Inc. (MED) experienced a 5.26% drop in stock price, now trading at $19.09 with a trading volume of 88,265 shares and a turnover rate of 0.81%. The stoc

Shares of Medifast Inc (MED) surged 4.53% in mid-day trading on Nov 27. The stock reached an intraday high of $19.30, before settling at $19.15, up from its

Medifast Inc. (MED) experienced a notable stock decline with a 5.08% drop, trading at $18.87 per share. The trading volume was 81,106 shares, with a turnover ra

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive opportunity for investors. Read more here.

Medifast, Inc. (NYSE:MED) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President-Investor...

The following slide deck was published by Medifast, Inc.

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024

Revenue: $168.6 million, a decrease of 43.1% year-over-year.Gross Profit: $123.4 million, a decrease of 41.4% year-over-year.Gross Profit Margin: Improved by 2

Aug 05, 2024 / 08:30PM GMTOperator And welcome to the Medifast second quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this confere

Shares of Medifast Inc (MED) fell 4.39% in mid-day trading on Sep 25. The stock reached an intraday low of $18.05, before recovering slightly to $18.31, dow

UAE-based Lytus Technologies Holdings PTV. Ltd. (LYT) is up over 109 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

New Jersey-based Cyclacel Pharmaceuticals, Inc. (CYCC), a clinical-stage biopharmaceutical company is up over 48% in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.